The role of alemtuzumab in the treatment of chronic lymphocytic leukemia

Clive S. Zent

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)175-176
Number of pages2
JournalLeukemia and Lymphoma
Volume49
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Neoplasm Antibodies
Salvage Therapy
B-Cell Chronic Lymphocytic Leukemia
Monoclonal Antibodies
alemtuzumab

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

The role of alemtuzumab in the treatment of chronic lymphocytic leukemia. / Zent, Clive S.

In: Leukemia and Lymphoma, Vol. 49, No. 2, 02.2008, p. 175-176.

Research output: Contribution to journalArticle

@article{43f4e7de5d264b0ea2809562b2c8b0b7,
title = "The role of alemtuzumab in the treatment of chronic lymphocytic leukemia",
author = "Zent, {Clive S.}",
year = "2008",
month = "2",
doi = "10.1080/10428190701809206",
language = "English (US)",
volume = "49",
pages = "175--176",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - The role of alemtuzumab in the treatment of chronic lymphocytic leukemia

AU - Zent, Clive S.

PY - 2008/2

Y1 - 2008/2

UR - http://www.scopus.com/inward/record.url?scp=38849161398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849161398&partnerID=8YFLogxK

U2 - 10.1080/10428190701809206

DO - 10.1080/10428190701809206

M3 - Article

C2 - 18231900

AN - SCOPUS:38849161398

VL - 49

SP - 175

EP - 176

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 2

ER -